Evidence map›Paper›PMID 42513422›Full record

ArticleJournal of clinical medicine2026

Treatment Switching and Drug Survival of Biologic Therapies in Psoriasis: A Real-World Italian Study Across Biologic Classes.

Silvia Calabria, Paolo Gisondi, Marina Talamonti, Lorenzo Giovanni Mantovani, Chiara Veronesi, Luca Degli Esposti

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Silvia CalabriaCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0001-9345-2855
Paolo GisondiSection of Dermatology and Venereology, Department of Medicine, University of Verona, 37129 Verona, Italy.ORCID 0000-0002-1777-9001
Marina TalamontiDepartment of Dermatology, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-3070-4071
Lorenzo Giovanni MantovaniResearch Centre on Public Health, University of Milano-Bicocca, 20900 Monza, Italy.
Chiara VeronesiCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0003-2852-2022
Luca Degli EspostiCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0002-7020-6659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-IL23anti-TNFαbiologic drugspsoriasisreal-world evidence

Identifiers

PMID42513422
PMCPMC13412808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.